B. Riley lowered the firm’s price target on Hyperfine (HYPR) to $1 from $1.20 and keeps a Buy rating on the shares. The Q1 sales miss was driven by the loss of several orders at large academic institutions that were funded by research grants, which was a result of the tension between academic institutions and the current administration, the analyst tells investors in a research note. The firm awaits more clarity in the second half of 2025.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HYPR: